Vimian: third-quarter revenue up 15%, organic growth at 11%
Vimian's third-quarter revenue rose 15% to €120.3 million, with 11% organic growth, according to TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Vimian's revenue in the third quarter grew 15% to €120.3 million. Organic growth reached 11%.
The two reports name the profit measure differently: one cites adjusted EBITA rising 14%, the other adjusted EBITDA up by the same percentage. Operating cash flow improved, and the company completed five acquisitions year to date. Cash conversion stood at 71%, but investments in MedTech and the scaling of Diagnostics continued to weigh on margins.
why it matters
For investors, the key point is that growth comes from both organic sales and deals, while cash generation is improving. Spending on MedTech and Diagnostics still holds back profitability. The exact profit metric should be checked in the original document, since the reports differ.
market impact
Vimian shares: strong results, but investment pressure on margins
tags
instruments
sources
- VIMIAN: Revenue grew 15%, with 11% organic growth and stronger operating cash flow — TradingView, 22 October 2026 at 05:49 UTC
- VIMIAN: Revenue rose 15% as double-digit organic growth and stronger cash conversion continued — TradingView, 22 October 2026 at 08:28 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗